Table II.

Transgenic mice that express the truncated apoL-I devoid of the SRA-interacting domain do not protect from infection with T. b. brucei or T. b. brucei-SRA

Transgenic DNA
Trypanosome species (1.78 × 106 injected i.p.)
Number mice alive/ number mice infected

 

 
Day 3
 
Day 50
 
ApoL-I T. b. brucei 5/5 3/5a 
Tr-apoL-I  0/5b  
Vector  0/5b  
ApoL-I T. b. brucei SRA 0/5b  
Tr-ApoL-I  0/5b  
Vector  0/5b  
Transgenic DNA
Trypanosome species (1.78 × 106 injected i.p.)
Number mice alive/ number mice infected

 

 
Day 3
 
Day 50
 
ApoL-I T. b. brucei 5/5 3/5a 
Tr-apoL-I  0/5b  
Vector  0/5b  
ApoL-I T. b. brucei SRA 0/5b  
Tr-ApoL-I  0/5b  
Vector  0/5b  

Tg mice expressing full-length apoL-I or truncated apoL-I infected with 1.78 x106T. b. brucei (Lister 427-derived line) or T. b. brucei-SRA (Lister 427-derived line expressing the SRA gene). n = 5 per group.

a

No parasites detectable.

b

Parasitemia ≥ 1 × 109/ml before mice were killed.

or Create an Account

Close Modal
Close Modal